Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001898714-22-000001
Filing Date
2022-11-29
Accepted
2022-11-29 09:35:53
Documents
1
Effectiveness Date
2022-11-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11636
  Complete submission text file 0001898714-22-000001.txt   12662
Mailing Address 1616 EASTLAKE AVENUE EAST SEATTLE WA 98102
Business Address 1616 EASTLAKE AVENUE EAST SEATTLE WA 98102 206-888-8485
Bonum Therapeutics, Inc. (Filer) CIK: 0001898714 (see all company filings)

EIN.: 872883314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-465970 | Film No.: 221428857